merged_ftc-pharmacy-benefit-managers-drug-prices.txt
<question_number>1</question_number>
<answer>N/A</answer>
<other>The text does not mention that the FTC decided to bring a lawsuit against pharmacy benefit managers. It only states that the FTC has so far stopped short of bringing a lawsuit or other enforcement action against a benefit manager.</other>
<question_number>2</question_number>
<answer>N/A</answer>
<other>The text does not provide the specific year when CVS Health acquired Caremark.</other>
<question_number>3</question_number>
<answer>$1.6 billion</answer>
<other>The FTC estimated that patients overpaid nearly $1.6 billion for generic drugs due to benefit manager practices over less than three years, according to the report.</other>